Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2016-10-04 Regulatory Filings
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Midkine Antibodies Show Anti-Tumor Activity In Brain Cancer 3 pages 116.0KB
Regulatory Filings Classification · 85% confidence The document is an ASX announcement from Cellmid Limited reporting preclinical study results on midkine antibodies showing anti-tumour activity against brain cancer. It details scientific findings, experimental results, and potential clinical development opportunities. There is no indication that this is a financial report, earnings release, regulatory filing, or management discussion. The content is a corporate announcement about research progress and collaboration opportunities, typical of a Capital/Financing Update or general corporate announcement. However, since it focuses on scientific and clinical development results rather than financing or capital structure changes, it does not fit CAP. It is not a regulatory filing or report publication announcement. Given the nature of the announcement as a corporate update on research progress, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous announcements that do not fit other categories.
2016-10-04 English
Cellmid 2016 Annual Report to Shareholders 74 pages 3.9MB
Regulatory Filings
2016-09-28 English
Quotation of Listed Options (CDYO) 1 page 92.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement regarding the quotation of listed options (CDYO) for Cellmid Limited, specifying the last date of quotation. It is a brief announcement about a market listing event rather than a financial report, management change, or detailed financial data. The document length is short (2746 characters) and contains no financial statements or detailed analysis. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital/Financing Update. It is a regulatory announcement related to stock market listing status, but not a delisting or capital change per se. Given the nature and length, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2016-09-27 English
Expiry Of Listed Options (CDYO) 3 pages 257.8KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement regarding the expiry of listed options (CDYO) for Cellmid Limited. It includes detailed information about the option exercise price, expiry date, terms and conditions of the options, and instructions for option holders on how to exercise their options. The document is not a financial report, earnings release, or management discussion but rather a formal notification to shareholders and option holders about the expiry and exercise process of listed options. It does not contain financial statements or analysis but focuses on capital structure changes related to option expiry and exercise. Therefore, it fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes such as option exercises.
2016-09-22 English
European Midkine Patent For Surgical Adhesion Allowed 2 pages 81.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement regarding the allowance of a European patent for a surgical adhesion treatment by Cellmid Limited. It discusses the patent details, the company's intellectual property portfolio, and the clinical development plans. There is no financial data, no regulatory filing references, no meeting materials, no voting results, no management or board changes, no earnings or interim reports, and no legal proceedings. The document is a corporate announcement about intellectual property and clinical development progress, typical of a general regulatory announcement. It does not fit into categories like Annual Report, Earnings Release, or Capital Update. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2016-09-21 English
Change of Director's Interest Notice 3 pages 140.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including number of shares before and after the change, nature of the change (on-market trade), and related contract interests. This is a clear report of personal share transactions by a company director. The document is not a financial report, earnings release, or management discussion, but specifically a director's dealing notice. Therefore, it fits the category 'Director's Dealing' (DIRS). The document length and content fully support this classification with high confidence.
2016-09-18 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.